198 related articles for article (PubMed ID: 9648150)
21. WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.
Kanemoto K; Ishikura K; Ariyasu D; Hamasaki Y; Hataya H; Hasegawa Y; Ikeda M
Pediatr Nephrol; 2007 Mar; 22(3):454-8. PubMed ID: 17061122
[TBL] [Abstract][Full Text] [Related]
22. Wilms' tumor and associated malformations; report of two cases with WAGR and Drash syndrome.
Ozbey H; Boneval C; Kapran Y; Aksöyek S; Salman T; Celik A
Eur J Pediatr Surg; 1996 Jun; 6(3):186-8. PubMed ID: 8817218
[TBL] [Abstract][Full Text] [Related]
23. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
24. Clinical spectrum of Denys-Drash and Frasier syndrome.
McTaggart SJ; Algar E; Chow CW; Powell HR; Jones CL
Pediatr Nephrol; 2001 Apr; 16(4):335-9. PubMed ID: 11354777
[TBL] [Abstract][Full Text] [Related]
25. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
[TBL] [Abstract][Full Text] [Related]
26. WT1 microdeletion and slowly progressing focal glomerulosclerosis in a patient with male pseudohermaphroditism, childhood leukemia, Wilms tumor and cerebellar angioblastoma.
Buglyó G; Méhes G; Vargha G; Biró S; Mátyus J
Clin Nephrol; 2013 May; 79(5):414-8. PubMed ID: 23618379
[TBL] [Abstract][Full Text] [Related]
27. Inherited WT1 mutation in Denys-Drash syndrome.
Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
[TBL] [Abstract][Full Text] [Related]
28. Novel WT1 mutation, 11p LOH, and t(7;12) (p22;q22) chromosomal translocation identified in a Wilms' tumor case.
Löbbert RW; Klemm G; Grüttner HP; Harms D; Winterpacht A; Zabel BU
Genes Chromosomes Cancer; 1998 Apr; 21(4):347-50. PubMed ID: 9559347
[TBL] [Abstract][Full Text] [Related]
29. A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema.
Wagner N; Wagner KD; Afanetti M; Nevo F; Antignac C; Michiels JF; Schedl A; Berard E
Pediatr Nephrol; 2008 Sep; 23(9):1445-53. PubMed ID: 18516627
[TBL] [Abstract][Full Text] [Related]
30. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
31. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
32. Regulation of renal EGF receptor expression is normal in Denys-Drash syndrome.
Vicanek C; Ferretti E; Goodyer C; Torban E; Moffett P; Pelletier J; Goodyer P
Kidney Int; 1997 Sep; 52(3):614-9. PubMed ID: 9291179
[TBL] [Abstract][Full Text] [Related]
33. Diaphragmatic hernia in Denys-Drash syndrome.
Devriendt K; Deloof E; Moerman P; Legius E; Vanhole C; de Zegher F; Proesmans W; Devlieger H
Am J Med Genet; 1995 May; 57(1):97-101. PubMed ID: 7645607
[TBL] [Abstract][Full Text] [Related]
34. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
[TBL] [Abstract][Full Text] [Related]
35. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
[TBL] [Abstract][Full Text] [Related]
36. [Hereditary renal tumors: Wilms' tumor--congenital anomalies' syndrome].
Tsuchida Y; Yokomori K; Choi SH
Nihon Rinsho; 1995 Nov; 53(11):2742-8. PubMed ID: 8538037
[TBL] [Abstract][Full Text] [Related]
37. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
38. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.
Coppes MJ; Huff V; Pelletier J
J Pediatr; 1993 Nov; 123(5):673-8. PubMed ID: 8229473
[No Abstract] [Full Text] [Related]
39. A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
Sakai A; Tadokoro K; Yanagisawa H; Nagafuchi S; Hoshikawa N; Suzuki T; Kohsaka T; Hasegawa T; Nakahori Y; Yamada M
Hum Mol Genet; 1993 Nov; 2(11):1969-70. PubMed ID: 8281164
[No Abstract] [Full Text] [Related]
40. WT1 and glomerular diseases.
Niaudet P; Gubler MC
Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
